The 2022 ISSCR Annual Meeting gathers the world’s leading scientists, clinicians, business leaders, ethicists, and educators from more than 65 countries. Together, we celebrate 20 years of excellence, advances, and contributions of stem cell research and regenerative medicine.
Join our co-founder Prof. Jose Polo and SAB member Prof. Christine Mummery at the Presidential Symposium on 15 June 2022.
Mogrify is transforming the lives of patients through the development of a novel class of in vivo reprogramming therapies, initially addressing indications in ophthalmology, otology and metabolic and other areas of degenerative disease. Using its proprietary suite of platform technologies to systematically identify the key transcriptomic and epigenetic switches required to drive direct cellular reprogramming.
Connect with our team at ISSCR 2022.